Proteogenomic Monitoring and Assessment of Liver Transplant Recipients
Recruiting · NCT01644903 · Observational (researchers observe without assigning treatment) · Lead sponsor: Northwestern University
View the official record on ClinicalTrials.gov →What this trial is about
This study is being done to test blood, urine and tissue samples to see if this can help decide if CKD (Chronic Kidney Disease), AR (Acute Rejection) and HCV (Hepatitis C Virus) can be identified in its early stages. CKD damage to the kidneys, AR and HCV all lower the body's ability to function properly. Early detection of these conditions could assist with successful treatment and possibly lead to less repeat organ transplants.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Male and female recipients of all races, ≥18 years of age.
- Patients undergoing primary or subsequent living or deceased donor liver transplantation.
- Subject and/or guardian must be able to provide informed consent.
- Subject and/or guardian must be able to comply with the study protocol.
Exclusion criteria
- \. Inability or unwillingness of a participant and/or guardian to provide informed consent.
Where it is running
1 location listed across 1 US state.
- Northwestern Memorial Hospital - Chicago, Illinois, United States